For example, inhibitor of kappa B (IκB) and nuclear factor κB (NF-κB) are often shown to be activated in the pathogenesis of inflammation-induced insulin resistance and T2DM [8, 9]. This evidence concerns the gene NFKB1 and type 2 diabetes mellitus.